中东和非洲肺移植治疗市场 – 行业趋势和 2029 年预测

>中东和非洲肺移植治疗市场，按产品（免疫抑制药物、器官保存产品、组织产品等）、适应症（慢性阻塞性肺病 (COPD)、肺纤维化、脓性肺病、肺动脉高压、囊性纤维化、间质性肺纤维化、肺气肿、结节病、原发性肺动脉高压等）、类型（尸体肺移植、活体肺移植）、技术（单肺移植、双侧肺移植、心肺移植和双肺移植）、患者人口统计（老年人、成人、儿童）、最终用户（医院、移植中心、专科中心等）、国家（沙特阿拉伯、南非、以色列、阿联酋、中东和非洲其他地区）行业趋势和预测至 2029 年

Pharmaceutical
MEA
350 页
表格数量: 119
图表数量: 45
最后更新日期: 2022年02月11日

中东和非洲肺移植治疗市场，按产品（免疫抑制药物、器官保存产品、组织产品等）、适应症（慢性阻塞性肺病 (COPD)、肺纤维化、脓性肺病、肺动脉高压、囊性纤维化、间质性肺纤维化、肺气肿、结节病、原发性肺动脉高压等）、类型（尸体肺移植、活体肺移植）、技术（单肺移植、双侧肺移植、心肺移植和双肺移植）、患者人口统计（老年人、成人、儿童）、最终用户（医院、移植中心、专科中心等）、国家（沙特阿拉伯、南非、以色列、阿联酋、中东和非洲其他地区）行业趋势和预测至 2029 年

市场分析和见解:中东和非洲肺移植疗法市场

中东和非洲肺移植治疗市场预计将在2022年至2029年的预测期内获得市场增长. 数据桥市场研究分析认为,在2022至2029年的预测期内,市场正在以2.5%的CAGR增长,预计到2029年将达到278万美元. 增加手术和治疗的新的创新治疗,并因污染增加而增加呼吸道慢性疾病,是预测期间可能推动市场需求的主要因素。

肺移植是一种手术程序,目的是去除不健康的肺并取而代之的是另一个人的健康肺. 肺部不健康或受损,使病人身体难以获得日常生存所需的氧气,例如呼吸,这种呼吸有助于平衡体内的pH值,在二氧化碳累积导致酸性升高时增加通风率,以释放出更多有害气体,从而有助于平衡pH值。哮喘等各种疾病,支气管和肺部发炎,肺部积聚出液体,肺癌和病情会损害肺部并妨碍肺部有效运作的能力.

药物批准率不断提高,临床试验率上升,慢性病发病率高,不断研究增加治疗应用,有望推动市场发展. 然而,捐献器官的人较少,肺移植程序费用高,可能妨碍市场增长。与此同时,保健支出的增加、市场参与者的战略举措、肺移植的技术进步,都为市场增长创造了机会。严格的监管框架和与肺移植有关的并发症可能给市场增长带来挑战。

中东和非洲肺移植疗法市场报告详细介绍了市场份额、新发展和产品管道分析、国内和地方市场参与者的影响,分析了新兴收入领域、市场监管变化、产品批准、战略决策、产品推出、地域扩张以及市场技术创新的机会。为了了解分析和市场情况,请与我们联系一个分析员简报;我们的小组将帮助你们建立一个收入影响解决方案,以实现所期望的目标。

中东和非洲肺移植疗法市场范围和市场规模

中东和非洲肺移植治疗市场分为产品、类型、指示、技术、病人人口统计和最终用户。不同部门之间的增长有助于你分析特殊的增长领域和接近市场的战略,并确定你的核心应用领域以及目标市场的差异。

在产品的基础上,中东和非洲肺移植疗法市场被分解为免疫抑制药物,组织产品,器官保存产品等. 2022年,由于免疫系统抑制剂药物在患者中的效力得到提高来避免肺部被拒,免疫抑制剂药物分会有望主导中东和非洲肺移植治疗市场.
根据类型,中东和非洲肺移植治疗市场被分入地壳肺移植和活肺移植. 2022年,由于器官捐赠及其应用的增加,地籍肺移植部分预计将主导中东和非洲肺移植治疗市场.
有迹象表明,中东和非洲肺移植治疗市场被划分为慢性阻塞性肺病、肺纤维化、化粪肺病。肺高血压, 囊肿纤维化,间起肺纤维化,肺气肿,主肺动脉高血压等. 2022年,由于该地区囊肿纤维化患者中易受感染的老年患者人数增多,预计囊肿纤维化部分将主导中东和非洲肺移植治疗市场.
以技术为基础,中东和非洲肺移植治疗市场被分入单肺移植,双边肺移植,心肺移植,双肺移植. 2022年,由于先进的肺移植程序激增,单齿移植(SLT)部分预计将主导中东和非洲肺移植治疗市场.
根据病人人口统计,中东和非洲肺移植治疗市场分为成人、儿科和老年病。 2022年,由于成人人口的增长,预计成年部分将主导中东和非洲肺移植治疗市场.
在最终用户的基础上,中东和非洲肺移植治疗市场被分成医院、移植中心、专科中心等。 2022年,预计医院部分将主导中东和非洲肺移植治疗市场,因为医院是拥有熟练医生的医疗保健和手术的有效地点,并且提高了对器官捐献、登记和慢性疾病的认识。

中东和非洲肺移植疗法市场国家层面分析

对中东和非洲肺移植疗法市场进行了分析,并根据产品、类型、指示、技术、病人人口和最终用户提供了市场规模信息。

中东和非洲肺移植治疗市场覆盖的一些国家有:沙特阿拉伯、南非、美国、以色列、埃及以及中东其他地区和非洲。

由于预防慢性病的临床试验和研究开发不断增多,预计中东和非洲区域的免疫抑制剂药物部分在2022至2029年的预测期内将以最高的增长率增长. 由于肺移植手术每年增加,沙特阿拉伯有望领导中东和非洲市场的增长,从而导致更多国家批准用于移植的药物。预计南非将占据主导地位,不断增加研发投资。

报告的国家部分还提供了影响市场的因素和影响市场当前和未来趋势的市场监管变化。诸如新的销售、替代销售、国家人口统计、监管法和进出口关税等数据点是用来预测个别国家市场情况的一些主要指针。此外,鉴于中东和非洲品牌的存在和可得性,以及它们因来自当地和国内品牌的大规模竞争或竞争稀少而面临的挑战,在提供国家数据的预测分析的同时,也考虑了销售渠道的影响。

保健支出和慢性疾病的上升推动了中东和非洲 肺移植治疗市场增长

中东和非洲肺移植治疗市场也为你们提供了详细的市场分析,说明每个国家肺移植工业的增长,销售额,肺移植技术进步的影响,以及它们支持肺移植治疗市场而改变的管理方案。现有2011至2020年历史时期的数据。

竞争性景观和中东和非洲肺移植疗法市场份额分析

中东和非洲肺移植疗法市场竞争环境提供了竞争对手提供的细节。详细内容有:公司概况,公司财务,创收,市场潜力,研发投资,新市场举措,生产地和设施,公司强弱,产品推出,产品试验管线,产品审批,专利,产品宽度,以及宽度,应用优势,技术命脉曲线等. 上述数据点仅与公司关注中东和非洲肺移植治疗市场有关.

一些中东和非洲肺移植治疗市场的主要制造商有:Bridge to Life Ltd, Viatris Inc., BioLife Solutions, Pfize Inc., F.Hoffmann-La Roche Ltd., Panacea Biotec Ltd., Agree-UK Ltd, Novartis AG, Hikma PLC, Reddy博士实验室有限公司等.

各种市场参与者提供更好的保健服务,这也正在加速中东和非洲肺移植治疗市场。

比如说,

2022年1月,希克玛制药公司PLC在加拿大以Teligent无菌注射器扩张,包括由25个无菌注射器产品,3个有许可证的眼科产品组成的组合,以及另外7个产品的管道,其中4个得到加拿大卫生部的批准. 这种令人振奋的产品组合将使公司能够扩大北美的业务,并在这一重要市场上发展稳固的地位.

合作、产品推出、业务扩展、奖赏和表彰、合资企业和其他市场参与者加强了中东和非洲肺移植治疗市场,这也有利于本组织改进其服务。

SKU-67628

在线获取全球首个市场情报云平台的报告访问权限

点击图片放大

交互式数据分析仪表板
用于发现高增长潜力机会的公司分析仪表板
研究分析师支持（定制与咨询）
带有交互式仪表板的竞争对手分析
最新新闻、更新与趋势分析
利用基准分析的强大功能，实现全面的竞争对手跟踪

申请演示

表格列表

TABLE 1 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 2 MIDDLE EAST AND AFRICA IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA CALCINEURIN INHIBITORS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA ANTIMETABOLITE IMMUNOSUPPRESANTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA M-TOR INHIBITOR IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA STEROIDS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA MONOCLONAL ANTIBODY IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA ORGAN PRESERVATION PRODUCTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA ORGAN PRESERVATION PRODUCTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA TISSUE PRODUCT IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA OTHERS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TECHNIQUE, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA SINGLE-LUNG TRANSPLANT (SLT) IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA DOUBLE LUNG TRANSPLANT IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA BILATERAL LUNG TRANSPLANT (BLT) IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA HEART-LUNG TRANSPLANT IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PATIENT DEMOGRAPHICS, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA ADULTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA GERIATRIC IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA PEDIATRIC IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA CADAVERIC LUNG TRANSPLANT IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA LIVING LUNG TRANSPLANT IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA CYSTIC FIBROSIS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA PULMONARY FIBROSIS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA INTERSTITIAL PULMONARY FIBROSIS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA PULMONARY HYPERTENSION IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA PRIMARY PULMONARY ARTERIAL HYPERTENSION IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA EMPHYSEMA IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA SARCOIDOSIS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA SEPTIC LUNG DISEASE IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA OTHERS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA HOSPITAL IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA TRANSPLANT CENTERS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA SPECIALTY CENTERS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA OTHERS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA CALCINEURIN INHIBITORS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA ANTIMETABOLITE IMMUNOSUPPRESANTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA M-TOR INHIBITOR IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA STEROIDS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA MONOCLONAL ANTIBODY IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA IMMUNOSUPRRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA IMMUNOSUPPRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA ORGAN PRESERVATION PRODUCTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TECHNIQUE, 2020-2029 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PATIENT DEMOGRAPHICS, 2020-2029 (USD MILLION)

TABLE 58 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 59 SAUDI ARABIA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 60 SAUDI ARABIA IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 61 SAUDI ARABIA CALCINEURIN INHIBITORS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 62 SAUDI ARABIA ANTIMETABOLITE IMMUNOSUPPRESANTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 63 SAUDI ARABIA M-TOR INHIBITOR IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 64 SAUDI ARABIA STEROIDS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 65 SAUDI ARABIA MONOCLONAL ANTIBODY IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 66 SAUDI ARABIA IMMUNOSUPRRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 67 SAUDI ARABIA IMMUNOSUPPRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 68 SAUDI ARABIA ORGAN PRESERVATION PRODUCTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 69 SAUDI ARABIA LUNG TRANSPLANT THERAPEUTICS MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 70 SAUDI ARABIA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 71 SAUDI ARABIA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TECHNIQUE, 2020-2029 (USD MILLION)

TABLE 72 SAUDI ARABIA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PATIENT DEMOGRAPHICS, 2020-2029 (USD MILLION)

TABLE 73 SAUDI ARABIA LUNG TRANSPLANT THERAPEUTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 74 SOUTH AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 75 SOUTH AFRICA IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 76 SOUTH AFRICA CALCINEURIN INHIBITORS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 77 SOUTH AFRICA ANTIMETABOLITE IMMUNOSUPPRESANTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 78 SOUTH AFRICA M-TOR INHIBITOR IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 79 SOUTH AFRICA STEROIDS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 80 SOUTH AFRICA MONOCLONAL ANTIBODY IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 81 SOUTH AFRICA IMMUNOSUPRRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 82 SOUTH AFRICA IMMUNOSUPPRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 83 SOUTH AFRICA ORGAN PRESERVATION PRODUCTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 84 SOUTH AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 85 SOUTH AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 86 SOUTH AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY TECHNIQUE, 2020-2029 (USD MILLION)

TABLE 87 SOUTH AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PATIENT DEMOGRAPHICS, 2020-2029 (USD MILLION)

TABLE 88 SOUTH AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 89 ISRAEL LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 90 ISRAEL IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 91 ISRAEL CALCINEURIN INHIBITORS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 92 ISRAEL ANTIMETABOLITE IMMUNOSUPPRESANTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 93 ISRAEL M-TOR INHIBITOR IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 94 ISRAEL STEROIDS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 95 ISRAEL MONOCLONAL ANTIBODY IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 96 ISRAEL IMMUNOSUPRRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 97 ISRAEL IMMUNOSUPPRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 98 ISRAEL ORGAN PRESERVATION PRODUCTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 99 ISRAEL LUNG TRANSPLANT THERAPEUTICS MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 100 ISRAEL LUNG TRANSPLANT THERAPEUTICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 ISRAEL LUNG TRANSPLANT THERAPEUTICS MARKET, BY TECHNIQUE, 2020-2029 (USD MILLION)

TABLE 102 ISRAEL LUNG TRANSPLANT THERAPEUTICS MARKET, BY PATIENT DEMOGRAPHICS, 2020-2029 (USD MILLION)

TABLE 103 ISRAEL LUNG TRANSPLANT THERAPEUTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 104 UAE LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 105 UAE IMMUNOSUPPRESSANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 106 UAE CALCINEURIN INHIBITORS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 107 UAE ANTIMETABOLITE IMMUNOSUPPRESANTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 108 UAE M-TOR INHIBITOR IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 109 UAE STEROIDS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 110 UAE MONOCLONAL ANTIBODY IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY CLASS, 2020-2029 (USD MILLION)

TABLE 111 UAE IMMUNOSUPRRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)

TABLE 112 UAE IMMUNOSUPPRESANT DRUGS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 113 UAE ORGAN PRESERVATION PRODUCTS IN LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 114 UAE LUNG TRANSPLANT THERAPEUTICS MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 115 UAE LUNG TRANSPLANT THERAPEUTICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 116 UAE LUNG TRANSPLANT THERAPEUTICS MARKET, BY TECHNIQUE, 2020-2029 (USD MILLION)

TABLE 117 UAE LUNG TRANSPLANT THERAPEUTICS MARKET, BY PATIENT DEMOGRAPHICS, 2020-2029 (USD MILLION)

TABLE 118 UAE LUNG TRANSPLANT THERAPEUTICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 119 REST OF MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: MARKET END USERS COVERAGE GRID

FIGURE 8 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 TECHNOLOGICAL ADVANCEMENTS IN HEALTHCARE AND SURGICAL SEGMENTS ASSOCIATED WITH ORGAN TRANSPLANTATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 13 IMMUNOSUPPRESSANTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET IN 2022 & 2029

FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR LUNG TRANSPLANT THERAPEUTICS IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET

FIGURE 16 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PRODUCT, 2021

FIGURE 17 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PRODUCT, 2020-2029 (USD MILLION)

FIGURE 18 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 19 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 20 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TECHNIQUE, 2021

FIGURE 21 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TECHNIQUE, 2020-2029 (USD MILLION)

FIGURE 22 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TECHNIQUE, CAGR (2022-2029)

FIGURE 23 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TECHNIQUE, LIFELINE CURVE

FIGURE 24 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PATIENT DEMOGRAPHICS, 2021

FIGURE 25 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PATIENT DEMOGRAPHICS, 2020-2029 (USD MILLION)

FIGURE 26 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PATIENT DEMOGRAPHICS, CAGR (2022-2029)

FIGURE 27 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY PATIENT DEMOGRAPHICS, LIFELINE CURVE

FIGURE 28 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TYPE, 2021

FIGURE 29 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 30 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 31 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 32 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET : BY INDICATION, 2021

FIGURE 33 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET : BY INDICATION, 2020-2029 (USD MILLION)

FIGURE 34 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET : BY INDICATION, CAGR (2022-2029)

FIGURE 35 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET : BY INDICATION, LIFELINE CURVE

FIGURE 36 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET : BY END USER, 2021

FIGURE 37 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET : BY END USER, 2020-2029 (USD MILLION)

FIGURE 38 MIDDLE EAST AND AFRICA LUNG TRANSPLANT THERAPEUTICS MARKET : BY END USER, CAGR (2022-2029)

圖 39 中東與非洲肺移植治療市場：依最終使用者、生命線曲線

圖 40 中東和非洲肺移植治療市場：快照（2021 年）

圖 41 中東和非洲肺移植治療市場：依國家（2021 年）

圖 42 中東和非洲肺移植治療市場：依國家（2022 年和 2029 年）

圖 43 中東和非洲肺移植治療市場：依國家（2021 年和 2029 年）

圖 44 中東和非洲肺移植治療市場：按產品（2022-2029）

圖45中東和非洲肺移植治療市場：2021年公司份額（％）

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

常见问题

预测2022至2029年的预测期间,市场将以何种增长率增长?

在2022至2029年的预测期间,中东和非洲肺移植治疗市场正在增长,CAGR为2.5%

未来的市场价值是什么?

在2022至2029年的预测期内,中东和非洲肺移植治疗市场预计将达到278万美元。

谁是在市场上经营的主要角色?

中东和非洲肺移植疗法市场的主要制造商有:Bridge to Life Ltd, Viatris Inc., BioLife Solutions, Pfize Inc., F.Hoffmann-La Roche Ltd., Panacea Biotec Ltd., Agree-UK Ltd., Novartis AG, Hikma PLC, Reddy博士实验室有限公司等.

产品部分是什么?

中东和非洲肺移植疗法市场按产品分类,如免疫抑制药物、器官保存产品、组织产品等。

中东和非洲肺移植治疗市场 – 行业趋势和 2029 年预测

市场分析和见解:中东和非洲肺移植疗法市场

中东和非洲肺移植疗法市场范围和市场规模

中东和非洲肺移植疗法市场国家层面分析

竞争性景观和中东和非洲肺移植疗法市场份额分析

在线获取全球首个市场情报云平台的报告访问权限

目录

表格列表

图片列表

研究方法

可定制

常见问题

行业相关报告

中东和非洲肺移植治疗市场 – 行业趋势和 2029 年预测

市场分析和见解:中东和非洲肺移植疗法市场

中东和非洲肺移植疗法市场范围和市场规模

中东和非洲 肺移植疗法市场国家层面分析

竞争性景观和中东和非洲 肺移植疗法市场份额分析

在线获取全球首个市场情报云平台的报告访问权限

目录

表格列表

图片列表

研究方法

可定制

常见问题

行业相关报告

中东和非洲肺移植疗法市场国家层面分析

竞争性景观和中东和非洲肺移植疗法市场份额分析